CELU · Celularity Inc
United States · RS rating 34 · As of 2026-11-03
| Price | 0.82 USD |
|---|---|
| 1-day change | +1.8% |
| RS rating (overall / 1M / 3M / 12M) | 34 / 4 / 83 / 18 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 18 / 20 / 29 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +13.7% |
| Sales growth Q/Q | -7.9% |
| Distance from 52-week high | +61.1% |
| Market cap (USD) | $32.3M |